Rapport Therapeutics
Rapport Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
About Rapport Therapeutics
Based in the United States, Rapport Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Rapport Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of precision small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company utilizes its RAP technology platform to target specific neuronal receptor complexes, aiming to transform the standard of care for neurological diseases.
Explore Rapport Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.